Lou Tartaglia is a Managing Partner and Co-Founder of Cure Ventures. He has held leadership and investment roles across various biotech startups and venture capital firms.
At firms with a similar stage, sector and check size.
One email when Lou's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckLou Tartaglia is a Managing Partner and Co-Founder of Cure Ventures. He has held leadership and investment roles across various biotech startups and venture capital firms.
Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Lou in the subject. A warm intro from a founder Cure Ventures backed works better.
Partner at Third Rock Ventures; Chief Scientific Officer at Editas; Chief Scientific Officer at Rhythm; Chief Scientific Officer at Agios; Head of at 4:59; interim CEO at Entrada Therapeutics; Partner at 5AM Venture.
Last updated 2026-10-15. Is this you? Ask for a correction.